+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Jul 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 172
In the non-oncology precision medicine market, the application of molecular biology is to study the etiology of diseases other than cancer at the molecular level, so target-based therapy or individualized therapy can be used to cure patients' health-related problems.
Market Analysis and Insights: Global Non-Oncology Precision Medicine Market
In 2020, the global Non-Oncology Precision Medicine market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
Global Non-Oncology Precision Medicine Scope and Market Size
Non-Oncology Precision Medicine market is segmented by companies, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Oncology Precision Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on market size and forecast for the period 2016-2027.
Segment by Type, the Non-Oncology Precision Medicine market is segmented into Applied Sciences, Precision Diagnostics, Digital Health and Information Technology, Precision Therapeutics, etc.
Segment by Application, the Non-Oncology Precision Medicine market is segmented into Infectious Diseases, Neurology, Cardiovascular, Lifestyle and Endocrinology, Gastroenterology, Others, etc.
Regional and Country-level Analysis
The report offers exhaustive assessment of different region-wise and country-wise Non-Oncology Precision Medicine markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.
The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Competitive Landscape and Non-Oncology Precision Medicine Market Share Analysis
Non-Oncology Precision Medicine market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021. Details included are company description, major business, company total revenue and revenue generated in Non-Oncology Precision Medicine business, the date to enter into the Non-Oncology Precision Medicine market, Non-Oncology Precision Medicine product introduction, recent developments, etc.
The major vendors include Abbott Laboratories, Agilent Technologies, Inc., Asuragen, Inc., Almac Group, AstraZeneca PLC, Bristol Myers Squibb, bioMÂrieux SA., BGI, Danaher Corp., Illumina, Inc., Invitae Corporation, Opko Health, Inc., Teva Pharmaceutical Industries Ltd., etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Oncology Precision Medicine Market Size by Type: 2016 VS 2021 VS 2027
1.2.2 Applied Sciences
1.2.3 Precision Diagnostics
1.2.4 Digital Health and Information Technology
1.2.5 Precision Therapeutics
1.3 Market by Application
1.3.1 Global Non-Oncology Precision Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Infectious Diseases
1.3.3 Neurology
1.3.4 Cardiovascular
1.3.5 Lifestyle and Endocrinology
1.3.6 Gastroenterology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trend
2.1 Global Non-Oncology Precision Medicine Market Perspective (2016-2027)
2.2 Global Non-Oncology Precision Medicine Growth Trends by Regions
2.2.1 Non-Oncology Precision Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Non-Oncology Precision Medicine Historic Market Size by Regions (2016-2021)
2.2.3 Non-Oncology Precision Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Non-Oncology Precision Medicine Industry Trends
2.3.2 Non-Oncology Precision Medicine Market Drivers
2.3.3 Non-Oncology Precision Medicine Market Challenges
2.3.4 Non-Oncology Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Oncology Precision Medicine Players by Market Size
3.1.1 Players Covered: Ranking by Non-Oncology Precision Medicine Revenue
3.1.2 Global Top Non-Oncology Precision Medicine Players by Revenue (2016-2021)
3.1.3 Global Non-Oncology Precision Medicine Revenue Market Share by Players (2016-2021)
3.1.4 Global Non-Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non-Oncology Precision Medicine Market Concentration Ratio
3.2.1 Global Non-Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 5 and Top 10 Players by Non-Oncology Precision Medicine Revenue in 2020
3.3 Non-Oncology Precision Medicine Key Players Head office and Area Served
3.4 Key Players Non-Oncology Precision Medicine Product Solution and Service
3.5 Date of Enter into Non-Oncology Precision Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Global Non-Oncology Precision Medicine Breakdown Data by Type (2016-2027)
4.1 Global Non-Oncology Precision Medicine Historic Market Size by Type (2016-2021)
4.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2022-2027)
5 Global Non-Oncology Precision Medicine Breakdown Data by Application (2016-2027)
5.1 Global Non-Oncology Precision Medicine Historic Market Size by Application (2016-2021)
5.2 Non-Oncology Precision Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Non-Oncology Precision Medicine Market Size (2016-2027)
6.2 Key Non-Oncology Precision Medicine Players Market Share in North America (2020-2021)
6.3 North America Non-Oncology Precision Medicine Market Size by Country
6.3.1 North America Non-Oncology Precision Medicine Market Size by Country (2016-2021)
6.3.2 North America Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)
6.4 United States Market Size Analysis
6.4.1 United States Non-Oncology Precision Medicine Market Size (2016-2027)
6.4.2 United States Non-Oncology Precision Medicine Market Size by Type (2016-2027)
6.4.3 United States Non-Oncology Precision Medicine Market Size by Application (2016-2027)
6.5 Canada Market Size Analysis
6.5.1 Canada Non-Oncology Precision Medicine Market Size (2016-2027)
6.5.2 Canada Non-Oncology Precision Medicine Market Size by Type (2016-2027)
6.5.3 Canada Non-Oncology Precision Medicine Market Size by Application (2016-2027)
7 Europe
7.1 Europe Non-Oncology Precision Medicine Market Size (2016-2027)
7.2 Key Non-Oncology Precision Medicine Players Market Share in Europe (2020-2021)
7.3 Europe Non-Oncology Precision Medicine Market Size by Country
7.3.1 Europe Non-Oncology Precision Medicine Market Size by Country (2016-2021)
7.3.2 Europe Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)
7.4 Germany Market Size Analysis
7.4.1 Germany Non-Oncology Precision Medicine Market Size (2016-2027)
7.4.2 Germany Non-Oncology Precision Medicine Market Size by Type (2016-2027)
7.4.3 Germany Non-Oncology Precision Medicine Market Size by Application (2016-2027)
7.5 France Market Size Analysis
7.5.1 France Non-Oncology Precision Medicine Market Size (2016-2027)
7.5.2 France Non-Oncology Precision Medicine Market Size by Type (2016-2027)
7.5.3 France Non-Oncology Precision Medicine Market Size by Application (2016-2027)
7.6 U.K. Market Size Analysis
7.6.1 U.K. Non-Oncology Precision Medicine Market Size (2016-2027)
7.6.2 U.K. Non-Oncology Precision Medicine Market Size by Type (2016-2027)
7.6.3 U.K. Non-Oncology Precision Medicine Market Size by Application (2016-2027)
7.7 Italy Market Size Analysis
7.7.1 Italy Non-Oncology Precision Medicine Market Size (2016-2027)
7.7.2 Italy Non-Oncology Precision Medicine Market Size by Type (2016-2027)
7.7.3 Italy Non-Oncology Precision Medicine Market Size by Application (2016-2027)
7.8 Russia Market Size Analysis
7.8.1 Russia Non-Oncology Precision Medicine Market Size (2016-2027)
7.8.2 Russia Non-Oncology Precision Medicine Market Size by Type (2016-2027)
7.8.3 Russia Non-Oncology Precision Medicine Market Size by Application (2016-2027)
8 Asia-Pacific
8.1 Asia-Pacific Non-Oncology Precision Medicine Market Size (2016-2027)
8.2 Key Non-Oncology Precision Medicine Players Market Share in Asia-Pacific (2020-2021)
8.3 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region
8.3.1 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2016-2021)
8.3.2 Asia-Pacific Non-Oncology Precision Medicine Market Size Forecast by Region (2022-2027)
8.4 China Market Size Analysis
8.4.1 China Non-Oncology Precision Medicine Market Size (2016-2027)
8.4.2 China Non-Oncology Precision Medicine Market Size by Type (2016-2027)
8.4.3 China Non-Oncology Precision Medicine Market Size by Application (2016-2027)
8.5 Japan Market Size Analysis
8.5.1 Japan Non-Oncology Precision Medicine Market Size (2016-2027)
8.5.2 Japan Non-Oncology Precision Medicine Market Size by Type (2016-2027)
8.5.3 Japan Non-Oncology Precision Medicine Market Size by Application (2016-2027)
8.6 South Korea Market Size Analysis
8.6.1 South Korea Non-Oncology Precision Medicine Market Size (2016-2027)
8.6.2 South Korea Non-Oncology Precision Medicine Market Size by Type (2016-2027)
8.6.3 South Korea Non-Oncology Precision Medicine Market Size by Application (2016-2027)
8.7 India Market Size Analysis
8.7.1 India Non-Oncology Precision Medicine Market Size (2016-2027)
8.7.2 India Non-Oncology Precision Medicine Market Size by Type (2016-2027)
8.7.3 India Non-Oncology Precision Medicine Market Size by Application (2016-2027)
8.8 Australia Market Size Analysis
8.8.1 Australia Non-Oncology Precision Medicine Market Size (2016-2027)
8.8.2 Australia Non-Oncology Precision Medicine Market Size by Type (2016-2027)
8.8.3 Australia Non-Oncology Precision Medicine Market Size by Application (2016-2027)
8.9 China Taiwan Market Size Analysis
8.9.1 China Taiwan Non-Oncology Precision Medicine Market Size (2016-2027)
8.9.2 China Taiwan Non-Oncology Precision Medicine Market Size by Type (2016-2027)
8.9.3 China Taiwan Non-Oncology Precision Medicine Market Size by Application (2016-2027)
8.10 Indonesia Market Size Analysis
8.10.1 Indonesia Non-Oncology Precision Medicine Market Size (2016-2027)
8.10.2 Indonesia Non-Oncology Precision Medicine Market Size by Type (2016-2027)
8.10.3 Indonesia Non-Oncology Precision Medicine Market Size by Application (2016-2027)
8.11 Thailand Market Size Analysis
8.11.1 Thailand Non-Oncology Precision Medicine Market Size (2016-2027)
8.11.2 Thailand Non-Oncology Precision Medicine Market Size by Type (2016-2027)
8.11.3 Thailand Non-Oncology Precision Medicine Market Size by Application (2016-2027)
8.12 Malaysia Market Size Analysis
8.12.1 Malaysia Non-Oncology Precision Medicine Market Size (2016-2027)
8.12.2 Malaysia Non-Oncology Precision Medicine Market Size by Type (2016-2027)
8.12.3 Malaysia Non-Oncology Precision Medicine Market Size by Application (2016-2027)
9 Latin America
9.1 Latin America Non-Oncology Precision Medicine Market Size (2016-2027)
9.2 Key Non-Oncology Precision Medicine Players Market Share in Latin America (2020-2021)
9.3 Latin America Non-Oncology Precision Medicine Market Size by Country
9.3.1 Latin America Non-Oncology Precision Medicine Market Size by Country (2016-2021)
9.3.2 Latin America Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)
9.4 Mexico Market Size Analysis
9.4.1 Mexico Non-Oncology Precision Medicine Market Size (2016-2027)
9.4.2 Mexico Non-Oncology Precision Medicine Market Size by Type (2016-2027)
9.4.3 Mexico Non-Oncology Precision Medicine Market Size by Application (2016-2027)
9.5 Brazil Market Size Analysis
9.5.1 Brazil Non-Oncology Precision Medicine Market Size (2016-2027)
9.5.2 Brazil Non-Oncology Precision Medicine Market Size by Type (2016-2027)
9.5.3 Brazil Non-Oncology Precision Medicine Market Size by Application (2016-2027)
9.6 Argentina Market Size Analysis
9.6.1 Argentina Non-Oncology Precision Medicine Market Size (2016-2027)
9.6.2 Argentina Non-Oncology Precision Medicine Market Size by Type (2016-2027)
9.6.3 Argentina Non-Oncology Precision Medicine Market Size by Application (2016-2027)
10 Middle East & Africa
10.1 Middle East & Africa Non-Oncology Precision Medicine Market Size (2016-2027)
10.2 Key Non-Oncology Precision Medicine Players Market Share in Middle East & Africa (2020-2021)
10.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country
10.3.1 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2016-2021)
10.3.2 Middle East & Africa Non-Oncology Precision Medicine Market Size Forecast by Country (2022-2027)
10.4 Turkey Market Size Analysis
10.4.1 Turkey Non-Oncology Precision Medicine Market Size (2016-2027)
10.4.2 Turkey Non-Oncology Precision Medicine Market Size by Type (2016-2027)
10.4.3 Turkey Non-Oncology Precision Medicine Market Size by Application (2016-2027)
10.5 Saudi Arabia Market Size Analysis
10.5.1 Saudi Arabia Non-Oncology Precision Medicine Market Size (2016-2027)
10.5.2 Saudi Arabia Non-Oncology Precision Medicine Market Size by Type (2016-2027)
10.5.3 Saudi Arabia Non-Oncology Precision Medicine Market Size by Application (2016-2027)
10.6 UAE Market Size Analysis
10.6.1 UAE Non-Oncology Precision Medicine Market Size (2016-2027)
10.6.2 UAE Non-Oncology Precision Medicine Market Size by Type (2016-2027)
10.6.3 UAE Non-Oncology Precision Medicine Market Size by Application (2016-2027)
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview and Its Total Revenue
11.1.3 Abbott Laboratories Non-Oncology Precision Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Details
11.2.2 Agilent Technologies, Inc. Business Overview and Its Total Revenue
11.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Introduction
11.2.4 Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.2.5 Agilent Technologies, Inc. Recent Development
11.3 Asuragen, Inc.
11.3.1 Asuragen, Inc. Company Details
11.3.2 Asuragen, Inc. Business Overview and Its Total Revenue
11.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Introduction
11.3.4 Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.3.5 Asuragen, Inc. Recent Development
11.4 Almac Group
11.4.1 Almac Group Company Details
11.4.2 Almac Group Business Overview and Its Total Revenue
11.4.3 Almac Group Non-Oncology Precision Medicine Introduction
11.4.4 Almac Group Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.4.5 Almac Group Recent Development
11.5 AstraZeneca PLC
11.5.1 AstraZeneca PLC Company Details
11.5.2 AstraZeneca PLC Business Overview and Its Total Revenue
11.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Introduction
11.5.4 AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.5.5 AstraZeneca PLC Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview and Its Total Revenue
11.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Introduction
11.6.4 Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.6.5 Bristol Myers Squibb Recent Development
11.7 bioMÃÂrieux SA.
11.7.1 bioMÃÂrieux SA. Company Details
11.7.2 bioMÃÂrieux SA. Business Overview and Its Total Revenue
11.7.3 bioMÃÂrieux SA. Non-Oncology Precision Medicine Introduction
11.7.4 bioMÃÂrieux SA. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.7.5 bioMÃÂrieux SA. Recent Development
11.8 BGI
11.8.1 BGI Company Details
11.8.2 BGI Business Overview and Its Total Revenue
11.8.3 BGI Non-Oncology Precision Medicine Introduction
11.8.4 BGI Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.8.5 BGI Recent Development
11.9 Danaher Corp.
11.9.1 Danaher Corp. Company Details
11.9.2 Danaher Corp. Business Overview and Its Total Revenue
11.9.3 Danaher Corp. Non-Oncology Precision Medicine Introduction
11.9.4 Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.9.5 Danaher Corp. Recent Development
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Details
11.10.2 Illumina, Inc. Business Overview and Its Total Revenue
11.10.3 Illumina, Inc. Non-Oncology Precision Medicine Introduction
11.10.4 Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.10.5 Illumina, Inc. Recent Development
11.11 Invitae Corporation
11.11.1 Invitae Corporation Company Details
11.11.2 Invitae Corporation Business Overview and Its Total Revenue
11.11.3 Invitae Corporation Non-Oncology Precision Medicine Introduction
11.11.4 Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.11.5 Invitae Corporation Recent Development
11.12 Opko Health, Inc.
11.12.1 Opko Health, Inc. Company Details
11.12.2 Opko Health, Inc. Business Overview and Its Total Revenue
11.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Introduction
11.12.4 Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.12.5 Opko Health, Inc. Recent Development
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Details
11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview and Its Total Revenue
11.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Introduction
11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2016-2021)
11.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
12 Analyst's Viewpoints/Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Non-Oncology Precision Medicine Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027
Table 2. Key Players of Applied Sciences
Table 3. Key Players of Precision Diagnostics
Table 4. Key Players of Digital Health and Information Technology
Table 5. Key Players of Precision Therapeutics
Table 6. Global Non-Oncology Precision Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Non-Oncology Precision Medicine Market Size by Region (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Non-Oncology Precision Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Non-Oncology Precision Medicine Market Share by Regions (2016-2021)
Table 10. Global Non-Oncology Precision Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Non-Oncology Precision Medicine Market Share by Regions (2022-2027)
Table 12. Non-Oncology Precision Medicine Market Trends
Table 13. Non-Oncology Precision Medicine Market Drivers
Table 14. Non-Oncology Precision Medicine Market Challenges
Table 15. Non-Oncology Precision Medicine Market Restraints
Table 16. Ranking of Global Top Non-Oncology Precision Medicine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Global Non-Oncology Precision Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Non-Oncology Precision Medicine Market Share by Players (2016-2021)
Table 19. Global Top Non-Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Oncology Precision Medicine as of 2020)
Table 20. Global 5 Largest Players Market Share by Non-Oncology Precision Medicine Revenue (CR5 and HHI) (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Non-Oncology Precision Medicine Product Solution and Service
Table 23. Date of Enter into Non-Oncology Precision Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-Oncology Precision Medicine Market Size by Type (2016-2021) & (US$ Million)
Table 26. Global Non-Oncology Precision Medicine Revenue Market Share by Type (2016-2021)
Table 27. Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 28. Global Non-Oncology Precision Medicine Revenue Market Share by Type (2022-2027)
Table 29. Global Non-Oncology Precision Medicine Market Size by Application (2016-2021) & (US$ Million)
Table 30. Global Non-Oncology Precision Medicine Revenue Market Share by Application (2016-2021)
Table 31. Global Non-Oncology Precision Medicine Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 32. Global Non-Oncology Precision Medicine Revenue Market Share by Application (2022-2027)
Table 33. Key Players Non-Oncology Precision Medicine Revenue in North America (2020-2021) (US$ Million)
Table 34. North America Non-Oncology Precision Medicine Market Size by Countries (2016-2021) & (US$ Million)
Table 35. North America Non-Oncology Precision Medicine Market Size Share by Countries (2016-2021)
Table 36. North America Non-Oncology Precision Medicine Market Size by Countries (2022-2027) & (US$ Million)
Table 37. North America Non-Oncology Precision Medicine Market Size Share by Countries (2022-2027)
Table 38. Non-Oncology Precision Medicine Market Size (US$ Million) in United States, Breakdown by Type (2016-2021)
Table 39. Non-Oncology Precision Medicine Market Size (US$ Million) in United States, Breakdown by Type (2022-2027)
Table 40. Non-Oncology Precision Medicine Market Size (US$ Million) in United States, Breakdown by Application (2016-2021)
Table 41. Non-Oncology Precision Medicine Market Size (US$ Million) in United States, Breakdown by Application (2022-2027)
Table 42. Non-Oncology Precision Medicine Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021)
Table 43. Non-Oncology Precision Medicine Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027)
Table 44. Non-Oncology Precision Medicine Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021)
Table 45. Non-Oncology Precision Medicine Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027)
Table 46. Key Players Non-Oncology Precision Medicine Revenue in Europe (2020-2021) (US$ Million)
Table 47. Europe Non-Oncology Precision Medicine Market Size by Countries (2016-2021) & (US$ Million)
Table 48. Europe Non-Oncology Precision Medicine Market Size Share by Countries (2016-2021)
Table 49. Europe Non-Oncology Precision Medicine Market Size by Countries (2022-2027) & (US$ Million)
Table 50. Europe Non-Oncology Precision Medicine Market Size Share by Countries (2022-2027)
Table 51. Non-Oncology Precision Medicine Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021)
Table 52. Non-Oncology Precision Medicine Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027)
Table 53. Non-Oncology Precision Medicine Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021)
Table 54. Non-Oncology Precision Medicine Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027)
Table 55. Non-Oncology Precision Medicine Market Size (US$ Million) in France, Breakdown by Type (2016-2021)
Table 56. Non-Oncology Precision Medicine Market Size (US$ Million) in France, Breakdown by Type (2022-2027)
Table 57. Non-Oncology Precision Medicine Market Size (US$ Million) in France, Breakdown by Application (2016-2021)
Table 58. Non-Oncology Precision Medicine Market Size (US$ Million) in France, Breakdown by Application (2022-2027)
Table 59. Non-Oncology Precision Medicine Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021)
Table 60. Non-Oncology Precision Medicine Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027)
Table 61. Non-Oncology Precision Medicine Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021)
Table 62. Non-Oncology Precision Medicine Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027)
Table 63. Non-Oncology Precision Medicine Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021)
Table 64. Non-Oncology Precision Medicine Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027)
Table 65. Non-Oncology Precision Medicine Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021)
Table 66. Non-Oncology Precision Medicine Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027)
Table 67. Non-Oncology Precision Medicine Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021)
Table 68. Non-Oncology Precision Medicine Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027)
Table 69. Non-Oncology Precision Medicine Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021)
Table 70. Non-Oncology Precision Medicine Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027)
Table 71. Key Players Non-Oncology Precision Medicine Revenue in Asia-Pacific (2020-2021) (US$ Million)
Table 72. Asia-Pacific Non-Oncology Precision Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 73. Asia-Pacific Non-Oncology Precision Medicine Market Size by Regions (2022-2027) & (US$ Million)
Table 74. Non-Oncology Precision Medicine Market Size (US$ Million) in China, Breakdown by Type (2016-2021)
Table 75. Non-Oncology Precision Medicine Market Size (US$ Million) in China, Breakdown by Type (2022-2027)
Table 76. Non-Oncology Precision Medicine Market Size (US$ Million) in China, Breakdown by Application (2016-2021)
Table 77. Non-Oncology Precision Medicine Market Size (US$ Million) in China, Breakdown by Application (2022-2027)
Table 78. Non-Oncology Precision Medicine Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021)
Table 79. Non-Oncology Precision Medicine Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027)
Table 80. Non-Oncology Precision Medicine Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021)
Table 81. Non-Oncology Precision Medicine Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027)
Table 82. Non-Oncology Precision Medicine Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021)
Table 83. Non-Oncology Precision Medicine Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027)
Table 84. Non-Oncology Precision Medicine Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021)
Table 85. Non-Oncology Precision Medicine Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027)
Table 86. Non-Oncology Precision Medicine Market Size (US$ Million) in India, Breakdown by Type (2016-2021)
Table 87. Non-Oncology Precision Medicine Market Size (US$ Million) in India, Breakdown by Type (2022-2027)
Table 88. Non-Oncology Precision Medicine Market Size (US$ Million) in India, Breakdown by Application (2016-2021)
Table 89. Non-Oncology Precision Medicine Market Size (US$ Million) in India, Breakdown by Application (2022-2027)
Table 90. Non-Oncology Precision Medicine Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021)
Table 91. Non-Oncology Precision Medicine Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027)
Table 92. Non-Oncology Precision Medicine Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021)
Table 93. Non-Oncology Precision Medicine Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027)
Table 94. Non-Oncology Precision Medicine Market Size (US$ Million) in China Taiwan, Breakdown by Type (2016-2021)
Table 95. Non-Oncology Precision Medicine Market Size (US$ Million) in China Taiwan, Breakdown by Type (2022-2027)
Table 96. Non-Oncology Precision Medicine Market Size (US$ Million) in China Taiwan, Breakdown by Application (2016-2021)
Table 97. Non-Oncology Precision Medicine Market Size (US$ Million) in China Taiwan, Breakdown by Application (2022-2027)
Table 98. Non-Oncology Precision Medicine Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021)
Table 99. Non-Oncology Precision Medicine Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027)
Table 100. Non-Oncology Precision Medicine Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021)
Table 101. Non-Oncology Precision Medicine Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027)
Table 102. Key Players Non-Oncology Precision Medicine Revenue in Latin America (2020-2021) (US$ Million)
Table 103. Latin America Non-Oncology Precision Medicine Market Size by Countries (2016-2021) & (US$ Million)
Table 104. Latin America Non-Oncology Precision Medicine Market Size by Countries (2022-2027) & (US$ Million)
Table 105. Non-Oncology Precision Medicine Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021)
Table 106. Non-Oncology Precision Medicine Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027)
Table 107. Non-Oncology Precision Medicine Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021)
Table 108. Non-Oncology Precision Medicine Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027)
Table 109. Non-Oncology Precision Medicine Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021)
Table 110. Non-Oncology Precision Medicine Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027)
Table 111. Non-Oncology Precision Medicine Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021)
Table 112. Non-Oncology Precision Medicine Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027)
Table 113. Non-Oncology Precision Medicine Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021)
Table 114. Non-Oncology Precision Medicine Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027)
Table 115. Non-Oncology Precision Medicine Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021)
Table 116. Non-Oncology Precision Medicine Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027)
Table 117. Key Players Non-Oncology Precision Medicine Revenue in Middle East & Africa (2020-2021) (US$ Million)
Table 118. Middle East & Africa Non-Oncology Precision Medicine Market Size by Countries (2016-2021) & (US$ Million)
Table 119. Middle East & Africa Non-Oncology Precision Medicine Market Size by Countries (2022-2027) & (US$ Million)
Table 120. Non-Oncology Precision Medicine Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021)
Table 121. Non-Oncology Precision Medicine Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027)
Table 122. Non-Oncology Precision Medicine Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021)
Table 123. Non-Oncology Precision Medicine Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027)
Table 124. Non-Oncology Precision Medicine Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021)
Table 125. Non-Oncology Precision Medicine Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027)
Table 126. Non-Oncology Precision Medicine Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021)
Table 127. Non-Oncology Precision Medicine Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027)
Table 128. Non-Oncology Precision Medicine Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021)
Table 129. Non-Oncology Precision Medicine Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027)
Table 130. Non-Oncology Precision Medicine Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021)
Table 131. Non-Oncology Precision Medicine Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027)
Table 132. Abbott Laboratories Company Details
Table 133. Abbott Laboratories Business Overview
Table 134. Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 135. Abbott Laboratories Non-Oncology Precision Medicine Non-Oncology Precision Medicine Product
Table 136. Abbott Laboratories Recent Development
Table 137. Agilent Technologies, Inc. Company Details
Table 138. Agilent Technologies, Inc. Business Overview
Table 139. Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 140. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product
Table 141. Agilent Technologies, Inc. Recent Development
Table 142. Asuragen, Inc. Company Details
Table 143. Asuragen, Inc. Business Overview
Table 144. Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 145. Asuragen, Inc. Non-Oncology Precision Medicine Product
Table 146. Asuragen, Inc. Recent Development
Table 147. Almac Group Company Details
Table 148. Almac Group Business Overview
Table 149. Almac Group Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 150. Almac Group Non-Oncology Precision Medicine Product
Table 151. Almac Group Recent Development
Table 152. AstraZeneca PLC Company Details
Table 153. AstraZeneca PLC Business Overview
Table 154. AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 155. AstraZeneca PLC Non-Oncology Precision Medicine Product
Table 156. AstraZeneca PLC Recent Development
Table 157. Bristol Myers Squibb Company Details
Table 158. Bristol Myers Squibb Business Overview
Table 159. Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 160. Bristol Myers Squibb Non-Oncology Precision Medicine Product
Table 161. Bristol Myers Squibb Recent Development
Table 162. bioMÂrieux SA. Company Details
Table 163. bioMÂrieux SA. Business Overview
Table 164. bioMÂrieux SA. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 165. bioMÂrieux SA. Non-Oncology Precision Medicine Product
Table 166. bioMÂrieux SA. Recent Development
Table 167. BGI Company Details
Table 168. BGI Business Overview
Table 169. BGI Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 170. BGI Non-Oncology Precision Medicine Product
Table 171. BGI Recent Development
Table 172. Danaher Corp. Company Details
Table 173. Danaher Corp. Business Overview
Table 174. Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 175. Danaher Corp. Non-Oncology Precision Medicine Product
Table 176. Danaher Corp. Recent Development
Table 177. Illumina, Inc. Company Details
Table 178. Illumina, Inc. Business Overview
Table 179. Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 180. Illumina, Inc. Non-Oncology Precision Medicine Product
Table 181. Illumina, Inc. Recent Development
Table 182. Invitae Corporation Company Details
Table 183. Invitae Corporation Business Overview
Table 184. Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 185. Invitae Corporation Non-Oncology Precision Medicine Product
Table 186. Invitae Corporation Recent Development
Table 187. Opko Health, Inc. Company Details
Table 188. Opko Health, Inc. Business Overview
Table 189. Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 190. Opko Health, Inc. Non-Oncology Precision Medicine Product
Table 191. Opko Health, Inc. Recent Development
Table 192. Teva Pharmaceutical Industries Ltd. Company Details
Table 193. Teva Pharmaceutical Industries Ltd. Business Overview
Table 194. Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2016-2021) & (US$ Million)
Table 195. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product
Table 196. Teva Pharmaceutical Industries Ltd. Recent Development
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Oncology Precision Medicine Market Share by Type: 2020 & 2027
Figure 2. Applied Sciences Features
Figure 3. Precision Diagnostics Features
Figure 4. Digital Health and Information Technology Features
Figure 5. Precision Therapeutics Features
Figure 6. Global Non-Oncology Precision Medicine Market Share by Application: 2020 & 2027
Figure 7. Infectious Diseases Case Studies
Figure 8. Neurology Case Studies
Figure 9. Cardiovascular Case Studies
Figure 10. Lifestyle and Endocrinology Case Studies
Figure 11. Gastroenterology Case Studies
Figure 12. Others Case Studies
Figure 13. Non-Oncology Precision Medicine Report Years Considered
Figure 14. Global Non-Oncology Precision Medicine Market Share by Regions: 2016 VS 2021 VS 2027
Figure 15. Global Non-Oncology Precision Medicine Market Size YoY Growth 2016-2027 (US$ Million)
Figure 16. Global Non-Oncology Precision Medicine Market Share by Regions (2022-2027)
Figure 17. Global Non-Oncology Precision Medicine Market Share by Players in 2020
Figure 18. Global Top Non-Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Oncology Precision Medicine as of 2020)
Figure 19. The Top 10 and 5 Players Market Share by Non-Oncology Precision Medicine Revenue in 2020
Figure 20. North America Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. United States Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Germany Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. France Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. U.K. Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Italy Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Russia Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Asia-Pacific Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. China Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Japan Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. South Korea Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. India Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Australia Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. China Taiwan Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Indonesia Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Thailand Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Malaysia Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Latin America Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Mexico Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Brazil Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Argentina Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Middle East & Africa Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Turkey Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Saudi Arabia Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. UAE Non-Oncology Precision Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
